Fundraising Fox
/Companies
Sign in

ELIAS Animal Health

Olathe, US · Founded 2014 · Delaware LLC · 9 employees on LinkedIn

Find your way into ELIAS Animal Health

Each arrow is one introduction. Sign up to fill in the first one.

231 people can intro you to Tammie

Ask Keith Harrington to introduce you to Tammie A. Wahaus

You →Keith · together at TVAX Biomedical, Inc. →Tammie

Sign up to find every way you can get introduced to ELIAS Animal Health

  • Your email: who you already know at ELIAS Animal Health, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ELIAS Animal Health team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

ELIAS Animal Health develops ELIAS Cancer Immunotherapy (ECI®), a personalized cancer treatment for dogs that combines an autologous vaccine with adoptive T cell therapy to target a patient's own cancer cells. The USDA-approved treatment for canine bone cancer is delivered through veterinarians and veterinary hospitals at authorized treatment centers across the United States.

BiotechHealthtech

Founders & leadership

ELIAS Animal Health was founded in 2014 by Tammie A. Wahaus.

TATammie A. Wahaus
Tammie A. WahausFounder, Chief Executive Officer and Board ChairTammie A. Wahaus is a business and financial executive with experience in strategic planning, financing, M&A, and compliance across biotechnology, telecommunications, financial services, and other industries, including advisory work with Fortune 100 companies.

Board

CB
Charles BurtonBoard director
CS
Chuck StephensBoard director
GW
Gary WoodBoard director
LM
Larry MaddoxBoard director
MP
Mark PattersonBoard director

Reported raises · per SEC filings

Form D private placements

$3.4M disclosed across 3 rounds · 2014–2017

▶$714.3KraisedMay 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles BurtonDirector
  • Chuck StephensDirector
  • Tammie A. WahausExecutive Officer, Director
  • Gary WoodDirector
  • Mark PattersonDirector
  • Larry MaddoxDirector
Offering amount
$800K
Amount sold
$714.3K
Minimum investment
$25K
First sale
Apr 2017
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$650.1KraisedJul 2016 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chuck StephensDirector
  • Gary WoodExecutive Officer
  • Larry MaddoxDirector
  • Tammie A. WahausExecutive Officer, Director
  • Charles BurtonDirector
  • Mark PattersonDirector
Offering amount
$1M
Amount sold
$650.1K
First sale
Jun 2016
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedApr 2015 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles BurtonDirector
  • Tammie A. WahausExecutive Officer
  • Chuck StephensDirector
  • Gary WoodDirector
  • Larry MaddoxDirector
  • Mark PattersonDirector
Offering amount
$2M
Amount sold
$2M
First sale
Nov 2014
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

ImpriMedImpriMedicine provides live-cell-based predictive analytics to identify effective drugs for treating blood cancers in dogs and cats, offering patient-specific drug response predictions. The company serves veterinary oncology and drug development efforts in the animal health field.
VcahospitalsVCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.
Petcure OncologyPetCure Oncology, founded in 2014, operates a network of veterinary cancer care centers offering stereotactic radiation therapy (SRS/SRT) and other cancer treatments for pets. It serves pet owners in the U.S. seeking advanced radiation oncology options for animals with cancer.

Companies working in the same space as ELIAS Animal Health.

In the news

ELIAS Animal Health Appoints Chief Revenue Officer; Launches Pursuit of $10M Series A Funding to Support Commercialization and Development of Innovative Canine Cancer Therapiesprnewswire.com · Apr 2024

Frequently asked questions

What does ELIAS Animal Health do?
ELIAS Animal Health develops ELIAS Cancer Immunotherapy (ECI®), a personalized cancer treatment for dogs that combines an autologous vaccine with adoptive T cell therapy to target a patient's own cancer cells. The USDA-approved treatment for canine bone cancer is delivered through veterinarians and veterinary hospitals at authorized treatment centers across the United States.
Who founded ELIAS Animal Health?
ELIAS Animal Health was founded by Tammie A. Wahaus in 2014.
How much funding has ELIAS Animal Health raised?
ELIAS Animal Health has disclosed $3.4M raised across 3 rounds.
Where is ELIAS Animal Health headquartered?
ELIAS Animal Health is headquartered in Olathe, US.